RTI Receives 510(k) Clearance for Allograft Paste Product

Regeneration Technologies (RTI), the Florida-based processor of orthopedic, cardiovascular and other allograft implants, announced that the company's bone paste product has received 510(k) clearance from the FDA. RTI's demineralized bone matrix (DBM) paste products consist of allograft DBM and a gelatin carrier. RTI allograft pastes are used in spinal and orthopedic to fill voids in bone.

ArriveNet (http://press.arrivenet.com/bus/article.php/587624.html)